Table 3 Clinical Outcomes at eight months.
Adverse Event | rhBNP (n = 75) Control (n = 79) no./total no.(%) | Difference (95% CI) | P value | |
|---|---|---|---|---|
Composite endpoints | 10/75 (13) | 20/79 (25.3) | − 12.3 (0.197–1.048) | 0.061 |
Target-vessel revascularization | 3/75 (4) | 5/79 (6.3) | − 2.3 (0.142—2.676) | 0.72 |
Recurrent angina | 7/75 (9) | 15/79 (19) | − 10 (0.168—1.147) | 0.087 |
